These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8496447)

  • 1. 6-Thioguanine therapy for psoriasis causing toxic hepatic venoocclusive disease.
    Kao NL; Rosenblate HJ
    J Am Acad Dermatol; 1993 Jun; 28(6):1017-8. PubMed ID: 8496447
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of psoriasis with 6-thioguanine and hepatic venoocclusive disease.
    Romagosa R; Kerdel F; Shah N
    J Am Acad Dermatol; 2002 Dec; 47(6):970-2; author reply 972. PubMed ID: 12451396
    [No Abstract]   [Full Text] [Related]  

  • 3. Ocular hemorrhage secondary to thioguanine-associated veno-occlusive disease in a child with acute lymphoblastic leukemia in delayed intensification.
    Bhunia N; Yeager ND; Colace SI; Buzzaco D; Bajwa RPS
    Pediatr Transplant; 2020 Feb; 24(1):e13638. PubMed ID: 31840375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thioguanine treatment-related sinusoidal obstruction syndrome in 2 children].
    Mao JQ; Zhao FY; Song H; Yang SL; Shen DY; Tang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep; 15(9):788-90. PubMed ID: 24034928
    [No Abstract]   [Full Text] [Related]  

  • 5. Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia.
    Stoneham S; Lennard L; Coen P; Lilleyman J; Saha V
    Br J Haematol; 2003 Oct; 123(1):100-2. PubMed ID: 14510948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI Patterns in a Case of 6-Thioguanine-Related Hepatic Sinusoidal Obstruction Syndrome.
    Marasco G; Scaioli E; Renzulli M; Colecchia A; Golfieri R; Festi D; Bazzoli F; Digby RJ; Belluzzi A
    Am J Gastroenterol; 2016 Jun; 111(6):767. PubMed ID: 27249976
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease.
    Kane S; Cohen SM; Hart J
    Inflamm Bowel Dis; 2004 Sep; 10(5):652-4. PubMed ID: 15472529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
    Lennard L; Richards S; Cartwright CS; Mitchell C; Lilleyman JS; Vora A;
    Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Thioguanine treatment of psoriasis: experience in 81 patients.
    Zackheim HS; Glogau RG; Fisher DA; Maibach HI
    J Am Acad Dermatol; 1994 Mar; 30(3):452-8. PubMed ID: 8113459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thioguanine treatment in psoriasis.
    Molin L; Thomsen K
    Acta Derm Venereol; 1987; 67(1):85-8. PubMed ID: 2436424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of psoriasis with 6-thioguanine.
    Zackheim HS; Maibach HI
    Australas J Dermatol; 1988; 29(3):163-7. PubMed ID: 3272126
    [No Abstract]   [Full Text] [Related]  

  • 12. DNA-TG and risk of sinusoidal obstruction syndrome in childhood acute lymphoblastic leukemia.
    Toksvang LN; Grell K; Nielsen SN; Nersting J; Murdy D; Moorman AV; Vora A; Schmiegelow K
    Leukemia; 2022 Feb; 36(2):555-557. PubMed ID: 34535761
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic veno-occlusive disease caused by 6-thioguanine.
    Gill RA; Onstad GR; Cardamone JM; Maneval DC; Sumner HW
    Ann Intern Med; 1982 Jan; 96(1):58-60. PubMed ID: 7053705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-thioguanine in the treatment of psoriasis: a case report and literature review.
    Sherer DW; Lebwohl MG
    J Cutan Med Surg; 2002; 6(6):546-50. PubMed ID: 12001005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioguanine for refractory psoriasis: a 4-year experience.
    Mason C; Krueger GG
    J Am Acad Dermatol; 2001 Jan; 44(1):67-72. PubMed ID: 11148479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-thioguanine as a cause of toxic veno-occlusive disease of the liver.
    Satti MB; Weinbren K; Gordon-Smith EC
    J Clin Pathol; 1982 Oct; 35(10):1086-91. PubMed ID: 6957419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic venoocclusive disease and perisinusoidal fibrosis secondary to arsenic poisoning.
    Labadie H; Stoessel P; Callard P; Beaugrand M
    Gastroenterology; 1990 Oct; 99(4):1140-3. PubMed ID: 2394335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity.
    Oancea I; Png CW; Das I; Lourie R; Winkler IG; Eri R; Subramaniam N; Jinnah HA; McWhinney BC; Levesque JP; McGuckin MA; Duley JA; Florin TH
    Gut; 2013 Apr; 62(4):594-605. PubMed ID: 22773547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatic veno-occlusive disease: report of two cases].
    Chen WX; Yang M; Yu CH; Li YM
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):394-5. PubMed ID: 15918986
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic veno-occlusive disease: MRI findings.
    Mortelé KJ; Van Vlierberghe H; Wiesner W; Ros PR
    Abdom Imaging; 2002; 27(5):523-6. PubMed ID: 12172990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.